文献速递肝病消化道肿瘤与早癌

慢性乙型肝炎患者HBsAg清除后肝细胞癌风险预测模型

Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B.
PubMed 文献 · Aliment Pharmacol Ther · 2026-03-23

该研究回顾性纳入3852例实现HBsAg清除的慢性乙型肝炎患者,随访21,711人年期间128例(3.3%)发生肝细胞癌(年发生率0.59%)。多因素分析确定年龄、男性、肝硬化、抗病毒治疗诱导的HBsAg清除及较低血小板和 albumin 水平为独立预测因素,构建的六因素模型Harrell's C-index为0.766,3年、5年和10年AUC分别为0.785、0.775和0.830。

要点

  • HBsAg清除后HCC年发生率为0.59%,仍需风险分层监测。
  • 六因素模型(年龄、性别、血小板、白蛋白、肝硬化、AVT诱导清除)区分度良好。
  • 模型3年、5年和10年AUC分别为0.785、0.775和0.830。

核心结论

  • 年龄≥50岁、男性、血小板≤150×10^9/L、白蛋白≤44 g/L、HBsAg清除时存在肝硬化及AVT诱导的HBsAg清除是HCC独立风险因素。
  • 六因素模型可对HBsAg清除患者进行风险分层,辅助临床监测策略。

研究设计与样本

  • 回顾性筛查2006年1月至2025年6月期间实现HBsAg清除的6536例CHB患者,最终3852例纳入分析。
  • 通过多因素Cox比例风险回归构建预测模型,Harrell's C-index和时间依赖ROC曲线AUC评估区分度,bootstrap重采样进行内部验证。

主要发现

  • 随访21,711人年期间,128例(3.3%)发生HCC,年发生率为0.59%。
  • 模型Harrell's C-index为0.766,3年、5年和10年AUC分别为0.785、0.775和0.830,内部验证区分度相似。

关键数值与推荐

  • 年龄≥50岁、男性、血小板计数≤150×10^9/L、白蛋白水平≤44 g/L、HBsAg清除时存在肝硬化、AVT诱导的HBsAg清除为独立预测因素。

临床怎么用

  • 对实现HBsAg清除的CHB患者,可依据六因素模型评估HCC风险并制定个体化监测策略。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prediction of hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) after hepatitis B surface antigen (HBsAg) seroclearance is important for optimizing surveillance strategies. AIM: This study aimed to identify independent risk factors of HCC after HBsAg seroclearance and to develop and validate a risk prediction model. METHODS: A total of 6536 CHB patients who achieved HBsAg seroclearance between January 2006 and June 2025 were retrospectively screened, with 3852 patients meeting the criteria for final analysis. A predictive model was developed via multivariate Cox proportional hazards regression analysis, with discrimination assessed using Harrell's C-index and time-dependent receiver operating characteristic curve area under the curve (AUC). Internal validation of the model was conducted through bootstrap resampling analysis. RESULTS: During 21,711 person-years of follow-up, 128 patients (3.3%) developed HCC (incidence rate: 0.59% per year). Multivariable analysis identified age, male sex, cirrhosis, antiviral therapy (AVT)-induced seroclearance and lower levels of platelets and albumin as independent predictors of HCC. The six independent variables were used for constructing the novel prediction model. Harrell's C-index of the model was 0.766. The novel model has a good predictive ability for HCC risk in the 3-year (AUC = 0.785), 5-year (AUC = 0.775) and 10-year (AUC = 0.830) with similar discriminative performance observed in internal validation. CONCLUSIONS: The independent risk factors of HCC occurrence are age ≥ 50 years, male, platelet count≤ 150 × 109/L, albumin level ≤ 44 g/L, with cirrhosis at HBsAg seroclearance and AVT-induced HBsAg seroclearance. Our six-factor model enables risk stratification among patients achieving HBsAg seroclearance and may assist in informing surveillance strategies in clinical practice.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ying S, Dai J, Zhang Q, et al. Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B. Aliment Pharmacol Ther. 2026. PMID: 41871984. doi:10.1111/apt.70637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。